MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Jeremie Urbain
Jeremie UrbainSERB PHARMACEUTICALS

Jeremie Urbain

Chairman at SERB PHARMACEUTICALS

Manager

Deal Bio

Total Deals3
Valued Deals3
Total Value£ 968 M
Avg. Deal Size£ 323 M

Market Context

Sort

01 Dec 2020|United States|Pharmaceuticals
Boston Scientific Corporation (btg Specialty Pharmaceuticals Business)
Charterhouse Capital Partners

Target: BOSTON SCIENTIFIC CORPORATION (BTG SPECIALTY PHARMACEUTICALS BUSINESS)

Bidder: CHARTERHOUSE CAPITAL PARTNERS

9 Service Providers

1 Target | 5 Bidder | 3 Vendor

43 Dealmakers

1 Target | 16 Bidder | 26 Vendor

£ 599 M

Value

31 Jul 2024|United States|Biotechnology
Emergent Biosolutions (reactive Skin Decontamination Lotion Assets)
Charterhouse Capital Partners

Target: EMERGENT BIOSOLUTIONS (REACTIVE SKIN DECONTAMINATION LOTION ASSETS)

Bidder: CHARTERHOUSE CAPITAL PARTNERS

4 Service Providers

4 Bidder

2 Dealmakers

2 Bidder

£ 58 M

Value

05 Aug 2025|United States|Biotechnology
Y-mabs Therapeutics
Serb Pharmaceuticals

Target: Y-MABS THERAPEUTICS INC

Bidder: SERB PHARMACEUTICALS

8 Service Providers

4 Target | 4 Bidder

25 Dealmakers

4 Target | 21 Bidder

£ 309 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Jeremie Urbain